ACXP
Price
$4.55
Change
-$0.01 (-0.22%)
Updated
Oct 3 closing price
Capitalization
7.21M
43 days until earnings call
OTLK
Price
$1.10
Change
+$0.04 (+3.77%)
Updated
Oct 6, 12:58 PM (EDT)
Capitalization
47.08M
Interact to see
Advertisement

ACXP vs OTLK

Header iconACXP vs OTLK Comparison
Open Charts ACXP vs OTLKBanner chart's image
Acurx Pharmaceuticals
Price$4.55
Change-$0.01 (-0.22%)
Volume$27.91K
Capitalization7.21M
Outlook Therapeutics
Price$1.10
Change+$0.04 (+3.77%)
Volume$904
Capitalization47.08M
ACXP vs OTLK Comparison Chart in %
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACXP vs. OTLK commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACXP is a Hold and OTLK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ACXP: $4.55 vs. OTLK: $1.06)
Brand notoriety: ACXP and OTLK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACXP: 25% vs. OTLK: 37%
Market capitalization -- ACXP: $7.21M vs. OTLK: $47.08M
ACXP [@Biotechnology] is valued at $7.21M. OTLK’s [@Biotechnology] market capitalization is $47.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACXP’s FA Score shows that 1 FA rating(s) are green whileOTLK’s FA Score has 1 green FA rating(s).

  • ACXP’s FA Score: 1 green, 4 red.
  • OTLK’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACXP and OTLK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACXP’s TA Score shows that 4 TA indicator(s) are bullish while OTLK’s TA Score has 6 bullish TA indicator(s).

  • ACXP’s TA Score: 4 bullish, 2 bearish.
  • OTLK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OTLK is a better buy in the short-term than ACXP.

Price Growth

ACXP (@Biotechnology) experienced а +12.35% price change this week, while OTLK (@Biotechnology) price change was +9.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.47%. For the same industry, the average monthly price growth was +12.91%, and the average quarterly price growth was +83.71%.

Reported Earning Dates

ACXP is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+5.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OTLK($47.1M) has a higher market cap than ACXP($7.21M). OTLK YTD gains are higher at: -43.915 vs. ACXP (-72.052). ACXP has higher annual earnings (EBITDA): -10.05M vs. OTLK (-42.64M). OTLK has more cash in the bank: 8.9M vs. ACXP (6.06M). ACXP has less debt than OTLK: ACXP (66.5K) vs OTLK (34.7M). OTLK has higher revenues than ACXP: OTLK (1.51M) vs ACXP (0).
ACXPOTLKACXP / OTLK
Capitalization7.21M47.1M15%
EBITDA-10.05M-42.64M24%
Gain YTD-72.052-43.915164%
P/E RatioN/A0.59-
Revenue01.51M-
Total Cash6.06M8.9M68%
Total Debt66.5K34.7M0%
FUNDAMENTALS RATINGS
OTLK: Fundamental Ratings
OTLK
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACXPOTLK
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPWR5.420.14
+2.65%
Ideal Power
CMRE11.93-0.01
-0.08%
Costamare
ACB5.65-0.03
-0.53%
Aurora Cannabis
BABA188.03-1.31
-0.69%
Alibaba Group Holding Limited
STVN25.98-0.42
-1.59%
Stevanato Group SpA

ACXP and

Correlation & Price change

A.I.dvisor tells us that ACXP and CERO have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACXP and CERO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACXP
1D Price
Change %
ACXP100%
-0.22%
CERO - ACXP
33%
Poorly correlated
-2.04%
HYPD - ACXP
31%
Poorly correlated
-6.42%
MGTX - ACXP
30%
Poorly correlated
+0.60%
OTLK - ACXP
29%
Poorly correlated
-0.93%
ATAI - ACXP
29%
Poorly correlated
+1.75%
More